Biocytogen Pharmaceuticals and Hansoh Pharmaceutical Group have announced an antibody collaboration, assignment and excl...
US-based Mission Bio and Abiosciences have announced a new partnership to co-develop bioinformatics packages for transla...
China-based GeneQuantum Healthcare (GQ) and WuXi XDC, a leading global Contract Research, Development and Manufacturing ...
On December 2nd, a nasal spray COVID-19 vaccine, VectorFlu ONE, was approved for emergency use (EU) by the national auth...
Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment startup...
Merck, and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical in China), a clinical-stage biotech compa...
The Hong Kong Polytechnic University (PolyU) has joined hands with Aier Eye Hospital Group to provide six to eight weeks...
China-based XtalPi, a pioneering pharmaceutical technology startup powered by artificial intelligence (AI) and automatio...
The Chinese University of Hong Kong (CUHK) has recently hosted the naming ceremony of the Peter Hung Pain Research Insti...
A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone amabolic therapies...
Hong Kong headquartered Prenetics Global is acquiring a majority stake in ACT Genomics Holdings Company, an Asia&nb...
Chinese biotech startup Stemirna Therapeutics has received an Emergency Use Authorisation (EUA) from the FDA for ...
XingImaging and Mitro Biotech will join forces to provide comprehensive contract research services in China. The company...
HKT's one-stop telemedicine platform DrGo has announced the introduction of first-in-Asia FibriCheck for atrial fibrilla...
Zhongke Guosheng (Hangzhou) Technology (GS Biotech) has announced the completion of its nearly CNY100 million pre-A roun...
China initiated a 10-year “Made in China 2025” plan in 2015 as part of a strategy to reduce dependence on fo...
Hong Kong Biotechnology Organization (HKBIO) is organising BIOHK2022 from 14-17th December convening global biotechnolog...
Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a ...
